Litcius/Paper detail

Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition

Tianyu Zhu, Xiu-Tao Wu, Chen Chen, Xiaoqin Liu, Li Zhu, Jian‐Guang Luo, Lingyi Kong

2022ACS Medicinal Chemistry Letters16 citationsDOIOpen Access PDF

Abstract

Harringtonolide (HO, 1) is a bioactive diterpenoid tropone isolated from Cephalotaxus harringtonia with antiproliferation activity. Until now there have been no reports to elucidate its anticancer mechanism. Herein we report the synthesis of HO-derived probes (10, 11, and 12) to identify the possible target of HO. As a result, the application of a novel photoaffinity alkyne-tagged probe from HO (compound 12) showed direct engagement between HO and receptor for activated C kinase 1 (RACK1). Furthermore, HO could suppress the epithelial–mesenchymal transition (EMT) process and inhibit activation of the FAK/Src/STAT3 signaling pathway in A375 cells. This study provides a groundwork for HO as an effective antitumor agent that targets RACK1 to suppress cancer cell migration.

Topics & Concepts

CancerComputer scienceChemistryMedicineInternal medicineNatural product bioactivities and synthesisBiological Activity of Diterpenoids and BiflavonoidsUbiquitin and proteasome pathways
Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition | Litcius